Fridolin Sulser: Difference between revisions
CSV import |
CSV import |
||
| Line 33: | Line 33: | ||
{{pharmacology-stub}} | {{pharmacology-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 13:07, 17 March 2025
Fridolin Sulser (1926–2016) was a Swiss-born American pharmacologist and neuroscientist who made significant contributions to the field of psychopharmacology. He is best known for his research on the neurotransmitter systems in the brain, particularly those involving serotonin and norepinephrine.
Early Life and Education[edit]
Sulser was born in Switzerland in 1926. He received his medical degree from the University of Zurich in 1951. He then moved to the United States to pursue further studies, earning a Ph.D. in pharmacology from the University of Illinois in 1956.
Career[edit]
After completing his Ph.D., Sulser joined the faculty of the Vanderbilt University School of Medicine in Nashville, Tennessee, where he served as a professor of pharmacology and psychiatry. He also held the position of director of the Division of Psychopharmacology at the Vanderbilt University Medical Center.
Sulser's research focused on the role of neurotransmitters in the brain, particularly serotonin and norepinephrine. He was among the first scientists to propose that these neurotransmitters play a crucial role in mood disorders such as depression and anxiety. His work has had a significant impact on the development of antidepressant drugs.
Legacy[edit]
Sulser's contributions to the field of psychopharmacology have been widely recognized. He received numerous awards and honors, including the Nathan S. Kline Award for Research in Psychopharmacology and the Paul Hoch Distinguished Service Award from the American College of Neuropsychopharmacology.
See Also[edit]
References[edit]
<references />
External Links[edit]
